What does this research mean for the field?

Gut microbiota is essential for mediating the systemic metabolic and hepatoprotective benefits, including reduced adiposity and fatty liver, of cardiac mitochondrial Akt1 activation in diet-induced diabetic cardiomyopathy. Novelty: ClaimNovelty.NOVEL_FINDING. Consensus alignment: ConsensusAlignment.ESTABLISHES_NEW_DIRECTION.

What question did this study set out to answer?

This research aims to determine if gut microbiota mediates the metabolic benefits from cardiac mitochondrial Akt1 activation.

June 7, 2026Diabetes

Microbiota depletion with antibiotics negated the metabolic benefits of cardiac mitochondrial Akt1 activation, resulting in 7% higher body fat mass compared to controls.

Q: What is the clinical evidence from this study?

Study design: Other. Population: Diet-Induced Diabetic Cardiomyopathy. Intervention: Broad-spectrum antibiotics (Ampicillin and Enrofloxacin) vs. Untreated CAMCAKT mice and non-induced vehicle injected controls. Primary outcome: Body fat mass.

View Full Paper

Ask AI

Bookmark

Why the study?

Does gut microbiota depletion with broad-spectrum antibiotics negate the metabolic benefits of cardiac mitochondrial Akt1 activation in a mouse model of diet-induced diabetic cardiomyopathy?

Population

Inducible myocardium-specific transgenic mouse model harboring a mitochondria-targeting constitutively…

Comparison

Broad-spectrum antibiotics to deplete gut… vs Non-induced vehicle injected CAMCAKT mice and…

Design

Preclinical

Follow-up

2 months

Key result

Microbiota depletion with antibiotics negated the metabolic benefits of cardiac mitochondrial Akt1 activation, resulting in 7% higher body fat mass compared to controls.

Authors

APAdrija Pathak ATALBERT TA RJROBERT JENQ

Discussion

Member takes

Overview

Gut microbiota depletion negates the metabolic and hepatoprotective benefits of cardiac mitochondrial Akt1 activation in a mouse model of diet-induced diabetic cardiomyopathy.

Key Points

This research aims to determine if gut microbiota mediates the metabolic benefits from cardiac mitochondrial Akt1 activation.
Used inducible myocardium-specific transgenic mouse model with activated Akt1.
Administered broad-spectrum antibiotics to some mice during high fat-high fructose diet feeding.
Compared body fat and liver composition between treated and control mice.
Antibiotic-treated CAMCAKT mice had 7% higher body fat mass compared to controls after 2 months on diet.
Untreated CAMCAKT mice showed an 8% lower body fat mass compared to controls.
Gut microbiota depletion reversed the metabolic benefits including improvements in fatty liver and body composition.

Structured PICO

Does gut microbiota depletion with broad-spectrum antibiotics negate the metabolic benefits of cardiac mitochondrial Akt1 activation in a mouse model of diet-induced diabetic cardiomyopathy?

Population

Inducible myocardium-specific transgenic mouse model (CAMCAKT) fed a high fat-high fructose diet for 2 months to assess the role of gut microbiota.

Intervention

Broad-spectrum antibiotics (Ampicillin and Enrofloxacin) to deplete gut microbiota

Comparator

Non-induced vehicle injected CAMCAKT mice (controls) and untreated CAMCAKT mice

Outcome

Body fat mass, serum free fatty acid levels, and hepatic steatosissurrogate

Gut microbiota depletion negates the metabolic and hepatoprotective benefits of cardiac mitochondrial Akt1 activation in a mouse model of diet-induced diabetic cardiomyopathy.

Cite This Study

Pathak et al. (2026) studied Diet-Induced Diabetic Cardiomyopathy. Broad-spectrum antibiotics (Ampicillin and Enrofloxacin) vs. Untreated CAMCAKT mice and non-induced vehicle injected controls was evaluated on Body fat mass. Microbiota depletion with antibiotics negated the metabolic benefits of cardiac mitochondrial Akt1 activation, resulting in 7% higher body fat mass compared to controls.

synapsesocial.com/papers/6a250ac07def13d035e1ace8 https://doi.org/10.2337/db26-2535-p

View Full Paper

Ask AI

Bookmark

June 7, 2026Diabetes

Microbiota depletion with antibiotics negated the metabolic benefits of cardiac mitochondrial Akt1 activation, resulting in 7% higher body fat mass compared to controls.

View Full Paper

Ask AI

Bookmark

Why the study?

Does gut microbiota depletion with broad-spectrum antibiotics negate the metabolic benefits of cardiac mitochondrial Akt1 activation in a mouse model of diet-induced diabetic cardiomyopathy?

Population

Inducible myocardium-specific transgenic mouse model harboring a mitochondria-targeting constitutively…

Comparison

Broad-spectrum antibiotics to deplete gut… vs Non-induced vehicle injected CAMCAKT mice and…

Design

Preclinical

Follow-up

2 months

Key result

Microbiota depletion with antibiotics negated the metabolic benefits of cardiac mitochondrial Akt1 activation, resulting in 7% higher body fat mass compared to controls.

Authors

APAdrija Pathak ATALBERT TA RJROBERT JENQ

Discussion

Member takes

Overview

Gut microbiota depletion negates the metabolic and hepatoprotective benefits of cardiac mitochondrial Akt1 activation in a mouse model of diet-induced diabetic cardiomyopathy.

Key Points

This research aims to determine if gut microbiota mediates the metabolic benefits from cardiac mitochondrial Akt1 activation.
Used inducible myocardium-specific transgenic mouse model with activated Akt1.
Administered broad-spectrum antibiotics to some mice during high fat-high fructose diet feeding.
Compared body fat and liver composition between treated and control mice.
Antibiotic-treated CAMCAKT mice had 7% higher body fat mass compared to controls after 2 months on diet.
Untreated CAMCAKT mice showed an 8% lower body fat mass compared to controls.
Gut microbiota depletion reversed the metabolic benefits including improvements in fatty liver and body composition.

Structured PICO

Does gut microbiota depletion with broad-spectrum antibiotics negate the metabolic benefits of cardiac mitochondrial Akt1 activation in a mouse model of diet-induced diabetic cardiomyopathy?

Population

Inducible myocardium-specific transgenic mouse model (CAMCAKT) fed a high fat-high fructose diet for 2 months to assess the role of gut microbiota.

Intervention

Broad-spectrum antibiotics (Ampicillin and Enrofloxacin) to deplete gut microbiota

Comparator

Non-induced vehicle injected CAMCAKT mice (controls) and untreated CAMCAKT mice

Outcome

Body fat mass, serum free fatty acid levels, and hepatic steatosissurrogate

Gut microbiota depletion negates the metabolic and hepatoprotective benefits of cardiac mitochondrial Akt1 activation in a mouse model of diet-induced diabetic cardiomyopathy.

Cite This Study

synapsesocial.com/papers/6a250ac07def13d035e1ace8 https://doi.org/10.2337/db26-2535-p

View Full Paper

Ask AI

Bookmark